DE69513293T2 - D-mannose- oder xylito-ester und ihre verwenung als arzneimittel - Google Patents
D-mannose- oder xylito-ester und ihre verwenung als arzneimittelInfo
- Publication number
- DE69513293T2 DE69513293T2 DE69513293T DE69513293T DE69513293T2 DE 69513293 T2 DE69513293 T2 DE 69513293T2 DE 69513293 T DE69513293 T DE 69513293T DE 69513293 T DE69513293 T DE 69513293T DE 69513293 T2 DE69513293 T2 DE 69513293T2
- Authority
- DE
- Germany
- Prior art keywords
- pct
- ester
- carbon atom
- grouping
- mannose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
- C07C69/614—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety of phenylacetic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/003—Esters of saturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9409348A FR2723096B1 (fr) | 1994-07-28 | 1994-07-28 | Esters associant les acides phenylacetique,3-phenyl-propionique, 4-phenyl-butyrique et n-butyrique au d-mannose, au xylitol et a leurs derives. applications comme medicaments |
PCT/FR1995/000743 WO1996003411A1 (fr) | 1994-07-28 | 1995-06-07 | Esters du d-mannose ou du xylitol et leur utilisation comme medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69513293D1 DE69513293D1 (de) | 1999-12-16 |
DE69513293T2 true DE69513293T2 (de) | 2000-03-23 |
Family
ID=9465834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69513293T Expired - Fee Related DE69513293T2 (de) | 1994-07-28 | 1995-06-07 | D-mannose- oder xylito-ester und ihre verwenung als arzneimittel |
Country Status (13)
Country | Link |
---|---|
US (1) | US5830872A (de) |
EP (1) | EP0773949B1 (de) |
JP (1) | JPH10505334A (de) |
AT (1) | ATE186543T1 (de) |
AU (1) | AU698677B2 (de) |
CA (1) | CA2196091A1 (de) |
DE (1) | DE69513293T2 (de) |
DK (1) | DK0773949T3 (de) |
ES (1) | ES2141359T3 (de) |
FR (1) | FR2723096B1 (de) |
GR (1) | GR3032545T3 (de) |
NZ (1) | NZ288263A (de) |
WO (1) | WO1996003411A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1286510B1 (it) * | 1996-11-29 | 1998-07-15 | Cooperativa Centro Ricerche Po | Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono |
WO2003062314A1 (en) * | 2002-01-16 | 2003-07-31 | Eastman Chemical Company | Novel carbohydrate esters and polyol esters as plasticizers for polymers, compositions and articles including such plasticizers and methods of using the same |
KR101286782B1 (ko) * | 2005-09-20 | 2013-07-17 | 디에스엠 아이피 어셋츠 비.브이. | 신규 카복실산 유도체 |
DE102005046237A1 (de) * | 2005-09-28 | 2007-04-05 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen |
FR2892635B1 (fr) * | 2005-10-28 | 2012-11-09 | Engelhard Lyon | Substance pour restaurer une co-expression et une interaction normales entre les proteines lox et nrage |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3053677A (en) * | 1959-11-12 | 1962-09-11 | Eastman Kodak Co | Petroleum wax for paper coatings |
IL37955A0 (en) * | 1970-11-13 | 1971-12-29 | Ciba Geigy Ag | O-esters of monosaccharides,their manufacture and pharmaceutical compositions containing them |
DE3229956A1 (de) * | 1982-08-12 | 1984-02-16 | Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf | Arzneimittel mit cytostatischer wirkung |
DE3239035A1 (de) * | 1982-10-19 | 1984-04-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | 2-phenoxypropionsaeurederivate von pentiten, verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit herbizider wirkung |
EP0316320B1 (de) * | 1986-07-11 | 1993-11-03 | Commonwealth Scientific And Industrial Research Organisation | Verminderung von fortpflanzungsausfällen |
FR2633929B2 (fr) * | 1987-09-25 | 1995-05-24 | Picardie Universite | Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees |
-
1994
- 1994-07-28 FR FR9409348A patent/FR2723096B1/fr not_active Expired - Fee Related
-
1995
- 1995-06-07 DE DE69513293T patent/DE69513293T2/de not_active Expired - Fee Related
- 1995-06-07 AT AT95922576T patent/ATE186543T1/de not_active IP Right Cessation
- 1995-06-07 CA CA002196091A patent/CA2196091A1/en not_active Abandoned
- 1995-06-07 JP JP8505506A patent/JPH10505334A/ja active Pending
- 1995-06-07 AU AU27422/95A patent/AU698677B2/en not_active Ceased
- 1995-06-07 DK DK95922576T patent/DK0773949T3/da active
- 1995-06-07 NZ NZ288263A patent/NZ288263A/en unknown
- 1995-06-07 ES ES95922576T patent/ES2141359T3/es not_active Expired - Lifetime
- 1995-06-07 EP EP95922576A patent/EP0773949B1/de not_active Expired - Lifetime
- 1995-06-07 WO PCT/FR1995/000743 patent/WO1996003411A1/fr not_active Application Discontinuation
- 1995-06-07 US US08/776,980 patent/US5830872A/en not_active Expired - Fee Related
-
2000
- 2000-02-02 GR GR20000400241T patent/GR3032545T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU698677B2 (en) | 1998-11-05 |
GR3032545T3 (en) | 2000-05-31 |
EP0773949A1 (de) | 1997-05-21 |
NZ288263A (en) | 1998-08-26 |
DE69513293D1 (de) | 1999-12-16 |
DK0773949T3 (da) | 2000-04-17 |
FR2723096A1 (fr) | 1996-02-02 |
FR2723096B1 (fr) | 1996-10-18 |
WO1996003411A1 (fr) | 1996-02-08 |
EP0773949B1 (de) | 1999-11-10 |
ATE186543T1 (de) | 1999-11-15 |
JPH10505334A (ja) | 1998-05-26 |
ES2141359T3 (es) | 2000-03-16 |
CA2196091A1 (en) | 1996-02-08 |
AU2742295A (en) | 1996-02-22 |
US5830872A (en) | 1998-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG102011A (en) | 1,3-propane diol derivatives as bioactive compounds(21) 102012 (22) 31.10.97 (13) l (19) bg (41) 29.05.98 (51) 6c 07 d 209/28 a (51) 6c 07 d 339/04 b (51) 6a 61 k 31/23 b (51) 6c 07 c 69/587 b (51) 6c 07 c 69/767 b (86) pct/gb96/01052,01.05.96 (87) wo96/34855,07.11.96 (31) 9508823 (32) 01.05.95 (33) gb (31) 9517107 (32) 21.08.95 (33) gb (31) 9605440 (32) 15.03.96 (33) gb (71) gb scotia holdings plc (72) gb horrobin, david f. (72) gb manku, mehar (72) gb mcmordie, austin (72) gb knowles, phillip (72) gb redden, peter (72) gb pitt, andrea (74) olga ruseva sirakova, (74) 1124 sofija,kompl."javorov",bl.19,vkh.g (54) fatty acid esters as bioactive compounds | |
CN100356909C (zh) | 源于白蜡蚧蜡的普利醇 | |
EP1077066A4 (de) | Prophylaktische-/heilmittel für hautkrankheiten | |
JPS568320A (en) | Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent | |
ITRM930356A0 (it) | Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. | |
Hikino et al. | Isolation and hypoglycemic activity of trichosans A, B, C, D, and E: glycans of Trichosanthes kirilowii roots1 | |
DE69513293T2 (de) | D-mannose- oder xylito-ester und ihre verwenung als arzneimittel | |
BG104286A (en) | Composition for the suppression of the symptoms of withdrawal and irresistible desire for alcohol in alcoholics and prevention of alcohol addiction among healthy patients | |
CN1338275A (zh) | 具有α一糖苷酶抑制剂活性的中药提取物、其制备方法及用途 | |
JPS5791913A (en) | Pharmaceutical preparation of drug | |
JP6076361B2 (ja) | 胃潰瘍の治療用医薬の調製におけるAlbizziachinensis抽出物の応用 | |
KR960700064A (ko) | 아연이 보충된 전립선 추출물 | |
GB2068964A (en) | 7-oxygenated sterol 3-glycosides | |
JPS57146587A (en) | New physiologically active substance mutastein and preparation thereof | |
KR870006081A (ko) | 신규 16,17-아세탈치환 프레그난 21-오익 에시드유도체 및 그의 제조방법 | |
CA2200516A1 (en) | Benzopyran derivative and method for treating heart disease using said benzopyran derivative | |
Abuye et al. | The effect of varying doses of oral iodized oil in the prophylaxis of endemic goitre in elementary schools children | |
JPS5834477B2 (ja) | クエルセチンの脂肪酸エステル | |
Dalen et al. | Antibodies against extractable components from Propionibacterium acnes in humans with and without acne vulgaris | |
CN1091022A (zh) | 一种中药擦剂 | |
ATE91079T1 (de) | Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen. | |
JP4014012B2 (ja) | 抗消化性潰瘍剤 | |
JP3517336B2 (ja) | 化粧料 | |
KR920007977A (ko) | 신규한 p-옥시벤조산 유도체, 그의 제조방법 및 의약으로서의 용도 | |
DANDEKAR et al. | Immunotherapeutical potential of Âyurvedic drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |